LDLR and atherosclerosis: Zirlik [136] reported that CD40 deficiency in Ldlr−/− mice does not ameliorate atherosclerosis, although the endothelial CD40-TNF receptor-related factor (TRAF) signaling pathways have been proven to promote atherosclerosis.